City

Berlin (1)

Condition

Myelodysplastic Syndromes (1)

Transfusion Dependent Iron Overload (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 4 (1)

Sponsor

Novartis Pharmaceuticals (1)

Collaborator

Intervention

icl670/deferasirox (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

transfusion dependent iron overload

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

MDS, Transfusion Dependent Iron Overload Trial in Berlin (ICL670/Deferasirox)

Completed

Myelodysplastic Syndromes
Transfusion Dependent Iron Overload

ICL670/Deferasirox

Berlin, Germany

Novartis Investigative Site

May 30, 2017